跳至主要内容
临床试验/NCT00204685
NCT00204685Unknown2 期

Beatmungsdauer Und Lungenfunktion Bei Beatmeten Patienten Unter Therapie Mit Dornase Alfa - Randomisierte, Doppel-Blinde, Placebo-Kontrollierte, Multizentrische, Prospektive Klinische Studie

University Hospital Tuebingen50 个研究点 分布在 1 个国家目标入组 540 人开始时间: 2003年8月最近更新:
适应症
相关药物

试验速览

阶段
2 期
入组人数
540
试验地点
50
主要终点
Time of mechanical ventilation from beginning of the ventilation-therapy up to the end of the ventilation-therapy

研究概览

简要总结

The purpose of this study is to determine whether Inhalation of Recombinant Human Deoxyribonuclease Shortens Ventilation Time in Mechanically Ventilated Adults

详细描述

Recombinant human deoxyribonuclease I (rhDNase, dornase alpha), administered by inhalation, is currently used as a mucolytic agent in the treatment of cystic fibrosis. This prospective, randomized, placebo-controlled, double-blind clinical study should carry out whether the therapeutic use of rhDNase can be extended to adults who are undergoing long term ventilation at the intensive care. It is hypothesized that mechanically ventilated patients show elevated concentrations of DNA in airway secretions, and that these pathological DNA levels are reduced by rhDNase. The primary clinical goal of the study is to establish wether ventilation times are shortend under inhalation of rhDNAse during the ventilation time. hDNase (verum) is compared with equal amounts of 0.9% saline solution (placebo).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • mechanical ventilation
  • expected ventilation time 3 days or longer
  • full therapy is possible
  • expectet ventilation time not longer than 21 days

排除标准

  • medicinal point of view: patient won´t survive the next 21 days
  • concomitant pneumococcal disease (like tuberculosis, carcinoma)
  • endotracheal bleeding
  • pneumothorax with no relief (e.g. thoracic drainage)
  • pregnancy
  • breast feeding
  • participation in another clinical trail
  • mechanical ventilation since more than 48 hours
  • mechanical ventilation on the basis of another reason than operation, trauma or pulmonary decompensation

结局指标

主要结局

Time of mechanical ventilation from beginning of the ventilation-therapy up to the end of the ventilation-therapy

次要结局

  • reduction of atelectasis / dystelectasis
  • improval of pulmonaryfunction
  • reduction of pneumonia
  • reduction of DNA concentrations in Airway Secretions
  • length of stay at the Intensive Care Unit
  • length of stay at the hospital

研究者

申办方类型
Other

研究点 (50)

Loading locations...

相似试验